105 related articles for article (PubMed ID: 38944085)
1. Synthesis of novel chitosan-Schiff bases nanoparticles for high efficiency Helicobacter pylori inhibition.
Hamed AA; Ali EA; Abdelhamid IA; Saad GR; Elsabee MZ
Int J Biol Macromol; 2024 Jun; 274(Pt 2):133499. PubMed ID: 38944085
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation against H. pylori of chitosan menthone Schiff base hybrid with different types of inorganic nanoparticles.
Hamed AA; Ali EA; Saad GR; Elsabee MZ
Int J Biol Macromol; 2024 Feb; 257(Pt 2):128742. PubMed ID: 38092112
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the in vitro anti-inflammatory and anti-Helicobacter pylori activities of chitosan-based biomaterials modified with copper oxide nanoparticles.
Elmehbad NY; Mohamed NA; Abd El-Ghany NA; Abdel-Aziz MM
Int J Biol Macromol; 2023 Dec; 253(Pt 6):127277. PubMed ID: 37806410
[TBL] [Abstract][Full Text] [Related]
4. Chitosan Schiff bases-based polyelectrolyte complexes with graphene quantum dots and their prospective biomedical applications.
Hamed AA; Saad GR; Abdelhamid IA; Elwahy AHM; Abdel-Aziz MM; Elsabee MZ
Int J Biol Macromol; 2022 May; 208():1029-1045. PubMed ID: 35378157
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of a short antimicrobial peptide (CM11) against Helicobacter pylori gastric infection using concanavalin A-coated chitosan nanoparticles.
Moosazadeh Moghaddam M; Bolouri S; Golmohammadi R; Fasihi-Ramandi M; Heiat M; Mirnejad R
J Mater Sci Mater Med; 2023 Aug; 34(9):44. PubMed ID: 37650975
[TBL] [Abstract][Full Text] [Related]
6. Sustainable antimicrobial modified chitosan and its nanoparticles hydrogels: Synthesis and characterization.
Ahmed ME; Mohamed HM; Mohamed MI; Kandile NG
Int J Biol Macromol; 2020 Nov; 162():1388-1397. PubMed ID: 32777418
[TBL] [Abstract][Full Text] [Related]
7. Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: an efficient candidate for Helicobacter pylori DNA vaccine.
Chehelgerdi M; Doosti A
J Nanobiotechnology; 2020 Apr; 18(1):63. PubMed ID: 32316990
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, anti-inflammatory and anti-Helicobacter pylori activities of novel benzophenone tetracarboxylimide benzoyl thiourea cross-linked chitosan hydrogels.
Mohamed NA; Abd El-Ghany NA; Abdel-Aziz MM
Int J Biol Macromol; 2021 Jun; 181():956-965. PubMed ID: 33878358
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial and antibiofilm activity of mannose-modified chitosan/PMLA nanoparticles against multidrug-resistant Helicobacter pylori.
Arif M; Ahmad R; Sharaf M; Samreen ; Muhammad J; Abdalla M; Eltayb WA; Liu CG
Int J Biol Macromol; 2022 Dec; 223(Pt A):418-432. PubMed ID: 36356866
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-based nanoparticles as delivery-carrier for promising antimicrobial glycolipid biosurfactant to improve the eradication rate of
Arif M; Sharaf M; Samreen ; Khan S; Chi Z; Liu CG
J Biomater Sci Polym Ed; 2021 Apr; 32(6):813-832. PubMed ID: 33428545
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of amoxicillin-loaded chitosan nanoparticles and inulin: A novel strategy for mitigating antibiotic resistance and preserving microbiota balance in Helicobacter pylori treatment.
Fayed B; Jagal J; Cagliani R; Kedia RA; Elsherbeny A; Bayraktutan H; Khoder G; Haider M
Int J Biol Macromol; 2023 Dec; 253(Pt 2):126706. PubMed ID: 37673144
[TBL] [Abstract][Full Text] [Related]
12. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity Enhancement of α-Mangostin with Folate-Conjugated Chitosan Nanoparticles in MCF-7 Breast Cancer Cells.
Herdiana Y; Wathoni N; Shamsuddin S; Muchtaridi M
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005306
[TBL] [Abstract][Full Text] [Related]
14. New potential anti-SARS-CoV-2 and anti-cancer therapies of chitosan derivatives and its nanoparticles: Preparation and characterization.
Ali M; Mohamed MI; Taher AT; Mahmoud SH; Mostafa A; Sherbiny FF; Kandile NG; Mohamed HM
Arab J Chem; 2023 May; 16(5):104676. PubMed ID: 36811068
[TBL] [Abstract][Full Text] [Related]
15. Characterization, Cytotoxicity, and Genotoxicity of TiO
Tao R; Wang C; Zhang C; Li W; Zhou H; Chen H; Ye J
Biol Trace Elem Res; 2018 Jul; 184(1):60-74. PubMed ID: 28993980
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
Kumar SP; Birundha K; Kaveri K; Devi KT
Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization, and in vitro cytotoxicity activity of allyl-isothiocyanate-embedded polymeric nanoparticles for potential breast cancer targeting.
Patil PB; Patel JK
Breast Cancer; 2023 Nov; 30(6):1065-1078. PubMed ID: 37695494
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and toxicology properties of α- and β-chitosan Maillard reaction products nanoparticles.
Zhang H; Zhang Y; Bao E; Zhao Y
Int J Biol Macromol; 2016 Aug; 89():287-96. PubMed ID: 27132881
[TBL] [Abstract][Full Text] [Related]
19. Fabrication and characterization of nanodelivery platform based on chitosan to improve the anticancer outcome of sorafenib in hepatocellular carcinoma.
Albalawi F; Hussein MZ; Fakurazi S; Masarudin MJ
Sci Rep; 2023 Jul; 13(1):12180. PubMed ID: 37500670
[TBL] [Abstract][Full Text] [Related]
20. Chitosan nanoparticles improve the effectivity of miltefosine against Acanthamoeba.
Latifi A; Esmaeili F; Mohebali M; Yasami-Khiabani S; Rezaeian M; Soleimani M; Kazemirad E; Amani A
PLoS Negl Trop Dis; 2024 Mar; 18(3):e0011976. PubMed ID: 38527059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
